Clinical Trials Browser

Recruiting × Melanoma × Influenza Vaccines × Clear all

NCT04697576 2026-03-10

Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma

Phase 1 Recruiting

Melanoma